NRx Pharmaceuticals and HOPE Therapeutics at NobleCon21
WILMINGTON, Del. — NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has exciting news to share. Together with HOPE Therapeutics, an innovative interventional psychiatry network under NRx, the organization is poised to present pivotal findings at NobleCon21. This is Noble Capital Markets' Twenty-First Annual Emerging Growth Equity Conference.
Exciting Presentation Scheduled
On December 3, the Founder and CEO of NRx, Jonathan Javitt, M.D., M.P.H, will take the stage to share insights during this important event. His presentation will kick off at 4:30 PM EST at the Florida Atlantic University, highlighting the company's ongoing progress in the fields of investigational drugs and therapies aimed at treating suicidal depression, PTSD, and related disorders.
Progress and Expansion
During the past year, NRx Pharmaceuticals has ramped up its initiatives in both drug development and clinical services. As they've noted, they are thrilled to report the generation of clinical revenue, showcasing significant advancements in their therapeutic offerings. Participants at NobleCon21 can expect a detailed overview of the strides made since NRx’s last appearance at the event.
Discounted Registration for Attendees
Investors and participants are encouraged to join the presentation at a special discounted rate. The registration code NRXPNOBLECON will grant access to this notable event. Interested parties are encouraged to secure their places soon, as it offers a unique opportunity to engage directly with key figures at NRx Pharmaceuticals.
Access to Video Webcast
For those unable to attend, NRx will provide a high-definition video webcast of the presentation. This will be available the day after the live event on the company's website. It's an excellent way to catch up on the information disseminated during the presentation and access a broader category of materials available from the Noble Capital Markets Conference.
About NRx Pharmaceuticals, Inc.
NRx Pharmaceuticals, Inc. is dedicated to developing innovative therapies designed especially for central nervous system disorders. Their clinical focus encompasses addressing complex conditions such as suicidal depression, PTSD, anxiety, and Autism. Unique in its approach, the company integrates cutting-edge drug development with an extensive network of clinics through HOPE Therapeutics, contributing to improved outcomes for patients through personalized care.
Looking Forward with NRX-100 and NRX-101
The company is making significant strides with its leading drug candidates: NRX-100, a preservative-free intravenous ketamine, and NRX-101, an oral combination therapy of D-cycloserine and lurasidone. Both therapies are designed to address the severe challenges of treating suicidal ideation in various depression forms. Notably, NRX-100's Fast Track Designation positions it uniquely within the market, signaling the potential for a timely solution for those in need.
The Role of HOPE Therapeutics
HOPE Therapeutics expands on the vision of NRx by establishing a network of clinics that provide state-of-the-art therapies, including TMS and Hyperbaric Oxygen Therapy. Their unique programming strives to deliver hope and healing to patients facing debilitating mental health challenges, especially in Florida where they are the first to offer the AMPA One Day treatment.
About Noble Capital Markets, Inc.
Noble Capital Markets has built a reputation for excellence in investment and advisory services since 1984. Their innovative approaches to investment banking are complemented by a comprehensive understanding of middle-market dynamics. NobleCon serves as a premier platform for emerging growth equity, showcasing multiple sectors and fostering connections between enterprises and investors.
Frequently Asked Questions
What is the focus of NRx Pharmaceuticals?
NRx Pharmaceuticals is focused on developing treatments for central nervous system disorders, specifically conditions like suicidal depression, PTSD, and anxiety.
When is NRx Pharmaceuticals presenting at NobleCon21?
The presentation is scheduled for December 3 at 4:30 PM EST at Florida Atlantic University.
How can attendees register for the conference?
Interested participants can register at a discounted rate using the code NRXPNOBLECON.
Where can I watch the presentation if I cannot attend live?
A high-definition video will be available on NRx Pharmaceuticals' website the day after the event.
What are NRX-100 and NRX-101?
NRX-100 is a preservative-free intravenous ketamine formulation, while NRX-101 is an oral therapy combining D-cycloserine and lurasidone, both targeting treatment for severe depression symptoms.
